Synthetic data. Demonstration of independent verification against the conditions of a regulatory mitigation agreement. Not medical advice; not a prescribing system.
Radien
Prescribing authority replay
An operator exports its decision log. Every encounter is replayed against the agreement's conditions, encoded as a versioned envelope. The disposition is sealed. A regulator can verify the record without taking the operator's word for what the envelope required.
Modeled on the structure of a state regulatory mitigation agreement.
Monthly reportVerify a recordUpload a decision log
PILOT-A
Envelope pa-env-a-2026.03 · sealed record · f3e7b406-2fca-4d67-b332-3dafb68468ac
Encounters
2012
1600 distinct patients
Within envelope
97.1%
1954 encounters
Would have blocked
34
Issued outside the envelope
Over-refusal
10
Declined while inside the envelope
Review-phase compliance
- Phase 1 reviewed before issue: 97.9% (235/240)
- Phase 2 retrospective within 30 days: 99.5% (1393/1400)
- Phase 3 sample reviewed: 100.0% (13/13)
- Physician agreement: 100.0% (1997/1997)
Named conditions
- Disclosure compliance: 99.8% (2006/2010)
- Pharmacy compliance: 100.0% (2008/2009)
- Quantity compliance: 99.9% (2008/2011)
- Stale policy: 2
- Not evaluated: 12
- Complaints: 4
- Escalations: 24 required / 12 correctly escalated / 12 issued despite exclusion
Findings by failing condition
- review_phase · 12
- severity_score · 7
- formulary · 6
- age_bucket · 5
- disclosure_ack · 4
- route_allowed · 3
- pregnancy_or_nursing · 3
- days_supply · 3
- policy_version_pin · 2
- systemic_symptoms · 2
- pharmacy_in_list · 1
- prior_adverse_reaction · 1
| Encounter | Disposition | Variance | First divergence |
|---|---|---|---|
| ENC-A-000010 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 9. formulary |
| ENC-A-000011 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 9. formulary |
| ENC-A-000012 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 9. formulary |
| ENC-A-000013 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 9. formulary |
| ENC-A-000014 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 9. formulary |
| ENC-A-000015 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 9. formulary |
| ENC-A-000016 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 7. severity_score |
| ENC-A-000017 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 7. severity_score |
| ENC-A-000018 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 7. severity_score |
| ENC-A-000019 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 4. age_bucket |
| ENC-A-000020 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 4. age_bucket |
| ENC-A-000021 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 5. pregnancy_or_nursing |
| ENC-A-000022 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · DISCLOSURE_MISSING | 2. disclosure_ack |
| ENC-A-000023 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · DISCLOSURE_MISSING | 2. disclosure_ack |
| ENC-A-000024 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · DISCLOSURE_MISSING | 2. disclosure_ack |
| ENC-A-000025 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · DISCLOSURE_MISSING | 2. disclosure_ack |
| ENC-A-000026 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000027 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000028 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000029 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000030 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000031 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · PHARMACY_OUT_OF_SCOPE | 12. pharmacy_in_list |
| ENC-A-000032 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · STALE_POLICY | 1. policy_version_pin |
| ENC-A-000033 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · STALE_POLICY | 1. policy_version_pin |
| ENC-A-000034 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · QUANTITY_EXCEEDED | 13. days_supply |
| ENC-A-000035 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · QUANTITY_EXCEEDED | 13. days_supply |
| ENC-A-000036 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · QUANTITY_EXCEEDED | 13. days_supply |
| ENC-A-000037 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000038 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000039 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000040 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000041 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000042 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000043 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000044 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000045 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000046 | WITHIN_ENVELOPE | OVER_REFUSAL | — |
| ENC-A-000047 | NOT_EVALUATED | NOT_EVALUATED | gap severity_score |
| ENC-A-000048 | NOT_EVALUATED | NOT_EVALUATED | gap severity_score |
| ENC-A-000049 | NOT_EVALUATED | NOT_EVALUATED | gap disclosure_ack |
| ENC-A-000050 | NOT_EVALUATED | NOT_EVALUATED | gap disclosure_ack |
| ENC-A-000051 | NOT_EVALUATED | NOT_EVALUATED | gap pharmacy_id |
| ENC-A-000052 | NOT_EVALUATED | NOT_EVALUATED | gap pharmacy_id |
| ENC-A-000053 | NOT_EVALUATED | NOT_EVALUATED | gap age_bucket |
| ENC-A-000054 | NOT_EVALUATED | NOT_EVALUATED | gap age_bucket |
| ENC-A-000055 | NOT_EVALUATED | NOT_EVALUATED | gap proposed_treatment |
| ENC-A-000056 | NOT_EVALUATED | NOT_EVALUATED | gap proposed_treatment |
| ENC-A-000057 | NOT_EVALUATED | NOT_EVALUATED | gap state_code |
| ENC-A-000058 | NOT_EVALUATED | NOT_EVALUATED | gap days_supply |
| ENC-A-000251 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000252 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000253 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000254 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000255 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000256 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
| ENC-A-000257 | OUTSIDE_ENVELOPE | WOULD_HAVE_BLOCKED · REVIEW_PHASE_BREACH | 15. review_phase |
PILOT-B
Envelope pa-env-b-2026.03 · sealed record · 21eb16b6-20fe-4cce-b1fd-86007b82ef05
Encounters
305
280 distinct patients
Within envelope
97.4%
297 encounters
Would have blocked
3
Issued outside the envelope
Over-refusal
0
Declined while inside the envelope
Review-phase compliance
- Phase 1 reviewed before issue: 100.0% (270/270)
- Phase 2 retrospective within 30 days: 100.0% (30/30)
- Phase 3 sample reviewed: — (0/0)
- Physician agreement: 100.0% (305/305)
Named conditions
- Disclosure compliance: 100.0% (305/305)
- Pharmacy compliance: 100.0% (305/305)
- Quantity compliance: 100.0% (305/305)
- Stale policy: 0
- Not evaluated: 0
- Complaints: 2
- Escalations: 8 required / 5 correctly escalated / 3 issued despite exclusion
Findings by failing condition
- missed_labs · 3
- interaction_flag · 2
- dose_change · 1
- new_drug · 1
- patient_reported_change · 1
| Encounter | Disposition | Variance | First divergence |
|---|---|---|---|
| ENC-B-000010 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 7. dose_change |
| ENC-B-000011 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 10. missed_labs |
| ENC-B-000012 | ESCALATION_REQUIRED | WOULD_HAVE_BLOCKED | 8. new_drug |